Dr. Philip on Non-Operative Treatment Advances in CRC

Video

In Partnership With:

Tony Philip, MD, discusses advances made in the treatment of patients with colorectal cancer.

Tony Philip, MD, a medical oncologist at Monter Cancer Center of the North Shore, LIJ Cancer Institute, and an assistant professor of medicine at Hofstra-North Shore LIJ School of Medicine and New York Institute of Technology College of Osteopathic Medicine, discusses advances made in the treatment of patients with colorectal cancer (CRC).

Short-course radiotherapy, as examined in the phase 3 RAPIDO trial (NCT01558921), could have benefit to patients with CRC during the COVID-19 pandemic, as it reduces the time spent in a hospital or clinic setting, Philip says. As such, outcomes for response to this treatment can be preserved, Philip notes.

Additionally, findings from the phase 2 OPRA trial (NCT02008656), which helped to evolve the non-operative management of distal colon cancer, suggest that up-front chemoradiotherapy followed by chemotherapy could be a good strategy, Philip explains. This is important, as the method was not considered years ago, Philip concludes.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD